A citation-based method for searching scientific literature

Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC).
Aaron C Tan. Thorac Cancer 2020
Times Cited: 151



PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.
Ali S Alzahrani. Semin Cancer Biol 2019
Times Cited: 376




List of shared articles



Times cited

Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models.
Aurimas Stulpinas, Matas Sereika, Aida Vitkeviciene, Ausra Imbrasaite, Natalija Krestnikova, Audrone V Kalvelyte. Front Oncol 2023
0

Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathway.
Miao Wang, Weihua Tang, Nianjin Gong, Peijun Liu. Drug Dev Res 2022
1

A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma.
Zhi Zheng, Yanqi Li, Xiao Lu, Jiao Zhang, Quanxing Liu, Dong Zhou, Xufeng Deng, Yuan Qiu, Qian Chen, Hong Zheng,[...]. Comput Biol Med 2022
0

[Naphthalene allyl trifluoromethyl benzocyclopentanone inhibits proliferation and induces apoptosis of lung cancer A549 cells in vitro].
X Wu, J He, P Li, Y Wang, L Yan, J Ma. Nan Fang Yi Ke Da Xue Xue Bao 2022
0

Systematic Analysis of Stress Granule Regulators-Associated Molecular Subtypes Predicts Drug Response, Immune Response, and Prognosis in Non-Small Cell Lung Cancer.
Dan Wang, Jiangen Ao, Youwen Xiong, Xinyi Zhang, Weifang Zhang. Front Cell Dev Biol 2022
1

Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma.
Gina M Castellano, Saman Zeeshan, Olga B Garbuzenko, Hatim E Sabaawy, Jyoti Malhotra, Tamara Minko, Sharon R Pine. Mol Cancer Ther 2022
0

Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.
Panfeng Chen, Xiaoping Li, Xi Yu, Min Yang. Evid Based Complement Alternat Med 2022
1

Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer.
Lin Shi, Weiliang Zhu, Yuanyuan Huang, Lin Zhuo, Siyun Wang, Shaobing Chen, Bei Zhang, Bin Ke. Clin Transl Med 2022
12

Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Int J Mol Sci 2022
1

Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer.
Zihan Quan, Yang Yang, Hongmei Zheng, Yuting Zhan, Jiadi Luo, Yue Ning, Songqing Fan. J Cancer 2022
0

Silencing of CPSF7 inhibits the proliferation, migration, and invasion of lung adenocarcinoma cells by blocking the AKT/mTOR signaling pathway.
Weishao An, Fang Yu. Open Med (Wars) 2022
0

Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.
Jindi Huang, Liye Chen, Jiangxia Wu, Daiqiao Ai, Ji-Quan Zhang, Tie-Gen Chen, Ling Wang. J Med Chem 2022
0


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy